Dr Signoretti on the Development of Novel Biomarkers in RCC Using Tissue-Based Analyses
Sabina Signoretti, MD, discusses research into the development of novel spatial biomarkers in renal cell carcinoma utilizing tissue-based in situ analyses.
Stay updated with breaking news from Prostate Cancer Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sabina Signoretti, MD, discusses research into the development of novel spatial biomarkers in renal cell carcinoma utilizing tissue-based in situ analyses.
Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 -- INmune Bio Inc. announces that Mark Lowdell,... | June 11, 2023
Represents First Ever Natural Killer Immunotherapy trial in Metastatic Castration-Resistant Prostate CancerWebinar at 11AM ET on Friday, May 12. BOCA RATON, Fla., May 08, 2023 --... | May 8, 2023
The Gift of Life presented the American Valve & Hydrant president with an award that pays tribute to Jason Deli’s founder.
Next trial in RAS-mutated mCRC (ONSEMBLE) is a randomized Phase 2 trial to demonstrate onvansertib's contribution to SoC and position for a possible...